NO136204C - Fremgangsm}te for fremstilling av proteaseinhibitoren plasminostreptin. - Google Patents

Fremgangsm}te for fremstilling av proteaseinhibitoren plasminostreptin.

Info

Publication number
NO136204C
NO136204C NO491/73A NO49173A NO136204C NO 136204 C NO136204 C NO 136204C NO 491/73 A NO491/73 A NO 491/73A NO 49173 A NO49173 A NO 49173A NO 136204 C NO136204 C NO 136204C
Authority
NO
Norway
Prior art keywords
plasminostreptin
procedure
preparation
protease inhibitor
protease
Prior art date
Application number
NO491/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO136204B (sv
Inventor
Atsushi Kakinuma
Hiromu Sugino
Norihiko Moriya
Masao Isono
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO136204B publication Critical patent/NO136204B/no
Publication of NO136204C publication Critical patent/NO136204C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8142Aspartate protease (E.C. 3.4.23) inhibitors, e.g. HIV protease inhibitors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO491/73A 1972-02-08 1973-02-07 Fremgangsm}te for fremstilling av proteaseinhibitoren plasminostreptin. NO136204C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1413272A JPS5434837B2 (sv) 1972-02-08 1972-02-08

Publications (2)

Publication Number Publication Date
NO136204B NO136204B (sv) 1977-04-25
NO136204C true NO136204C (no) 1977-08-03

Family

ID=11852593

Family Applications (1)

Application Number Title Priority Date Filing Date
NO491/73A NO136204C (no) 1972-02-08 1973-02-07 Fremgangsm}te for fremstilling av proteaseinhibitoren plasminostreptin.

Country Status (12)

Country Link
US (1) US4014860A (sv)
JP (1) JPS5434837B2 (sv)
BE (1) BE794975A (sv)
CA (1) CA994692A (sv)
CH (1) CH575467A5 (sv)
DE (1) DE2304780A1 (sv)
DK (1) DK130477B (sv)
FR (1) FR2181710B1 (sv)
GB (1) GB1414696A (sv)
NL (1) NL7301822A (sv)
NO (1) NO136204C (sv)
SE (1) SE390543B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5941718B2 (ja) * 1980-01-31 1984-10-09 エスエス製薬株式会社 新規物質m−9337およびその製造法
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
JPS6138212A (ja) * 1984-07-30 1986-02-24 Aisin Warner Ltd 回転部材支持装置
US5279939A (en) * 1986-08-18 1994-01-18 Smithkline Beecham Corporation Protein protease inhibitors from streptomyces
DE3751131T2 (de) * 1986-08-18 1995-07-06 Smithkline Beckman Corp Proteinartiger Proteaseinhibitor aus Streptomyces.
EP0624642B1 (en) * 1993-05-12 1999-01-20 Indian Council For Medical Research Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740319A (en) * 1969-06-13 1973-06-19 Microbial Chem Res Found Biologically active substance,pepstatin and production processes thereof

Also Published As

Publication number Publication date
JPS5434837B2 (sv) 1979-10-29
FR2181710B1 (sv) 1976-07-02
SE390543B (sv) 1976-12-27
CA994692A (en) 1976-08-10
DK130477B (da) 1975-02-24
BE794975A (fr) 1973-05-29
DE2304780A1 (de) 1973-08-09
US4014860A (en) 1977-03-29
CH575467A5 (sv) 1976-05-14
JPS4882089A (sv) 1973-11-02
NL7301822A (sv) 1973-08-10
FR2181710A1 (sv) 1973-12-07
NO136204B (sv) 1977-04-25
DK130477C (sv) 1975-07-28
GB1414696A (en) 1975-11-19
USB328077I5 (sv) 1976-04-13

Similar Documents

Publication Publication Date Title
SE397257B (sv) Forfarande for framstellning av sackaroshaltiga sotningsmedel
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
CH553536A (de) Schaedlingsbekaempfungsmittel.
NO144223C (no) Fremgangsmaate til fremstilling av strekkbart papir
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
NO743493L (no) Utgangsmaterialer til bruk for fremstilling av substituerte omega-pentanorprostaglandiner.
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
NO139861C (no) Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner
NO143159C (no) Fremgangsmaate for fremstilling av metylmetakrylat-alkylakrylatkopolymerer.
FI55626B (fi) Anordning foer framstaellning av en behaollare
SE404525B (sv) Forfarande for framstellning av 4-aminometyl-cyklohexan-karboxylsyra-1
NO136204C (no) Fremgangsm}te for fremstilling av proteaseinhibitoren plasminostreptin.
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
FI53452C (fi) Foerfarande foer framstaellning av n-laegre-alkyl-1,4-dihydro-4-oxokinolin-3-karboxylsyror
NO138563C (no) Fremgangsmaate til fremstilling av alfa-6-deoksytetracykliner
NO141951C (no) Fremgangsmaate for oppslutning av loev-ved.
SE398500B (sv) Forfarande for framstellning av 2-(3-legre alkylamino-2-hydroxipropyl)-3-fenylpyrazin